These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27734914)

  • 21. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn's Disease of the Ileum.
    Chiodini RJ; Dowd SE; Chamberlin WM; Galandiuk S; Davis B; Glassing A
    PLoS One; 2015; 10(7):e0134382. PubMed ID: 26222621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.
    Faubion WA; Fletcher JG; O'Byrne S; Feagan BG; de Villiers WJ; Salzberg B; Plevy S; Proctor DD; Valentine JF; Higgins PD; Harris JM; Diehl L; Wright L; Tew GW; Luca D; Basu K; Keir ME
    Am J Gastroenterol; 2013 Dec; 108(12):1891-900. PubMed ID: 24126633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation.
    Sarrabayrouse G; Landolfi S; Pozuelo M; Willamil J; Varela E; Clark A; Campos D; Herrera C; Santiago A; Machiels K; Vermeire S; Martí M; Espin E; Manichanh C
    EBioMedicine; 2020 Jan; 51():102611. PubMed ID: 31901867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired innate immune function associated with fecal supernatant from Crohn's disease patients: insights into potential pathogenic role of the microbiome.
    Meelu P; Marin R; Clish C; Zella G; Cox S; Yajnik V; Nguyen DD; Korzenik JR
    Inflamm Bowel Dis; 2014 Jul; 20(7):1139-46. PubMed ID: 24892965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease progression-associated alterations in fecal metabolites in SAMP1/YitFc mice, a Crohn's disease model.
    Komatsu Y; Shimizu Y; Yamano M; Kikuchi M; Nakamura K; Ayabe T; Aizawa T
    Metabolomics; 2020 Apr; 16(4):48. PubMed ID: 32274593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysbiosis of the fecal microbiota in the TNBS-induced Crohn's disease mouse model.
    He Q; Li X; Liu C; Su L; Xia Z; Li X; Li Y; Li L; Yan T; Feng Q; Xiao L
    Appl Microbiol Biotechnol; 2016 May; 100(10):4485-94. PubMed ID: 26795965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
    Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E
    Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort.
    Sprockett D; Fischer N; Boneh RS; Turner D; Kierkus J; Sladek M; Escher JC; Wine E; Yerushalmi B; Dias JA; Shaoul R; Kori M; Snapper SB; Holmes S; Bousvaros A; Levine A; Relman DA
    Inflamm Bowel Dis; 2019 Nov; 25(12):1927-1938. PubMed ID: 31276165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
    Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
    Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin.
    Vázquez Morón JM; Pallarés Manrique H; Machancoses FH; Ramos Lora M; Ruiz Frutos C
    Rev Esp Enferm Dig; 2017 Feb; 109(2):130-136. PubMed ID: 28071062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volatile metabolites in breath strongly correlate with gut microbiome in CD patients.
    Smolinska A; Tedjo DI; Blanchet L; Bodelier A; Pierik MJ; Masclee AAM; Dallinga J; Savelkoul PHM; Jonkers DMAE; Penders J; van Schooten FJ
    Anal Chim Acta; 2018 Sep; 1025():1-11. PubMed ID: 29801597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery.
    Mondot S; Lepage P; Seksik P; Allez M; Tréton X; Bouhnik Y; Colombel JF; Leclerc M; Pochart P; Doré J; Marteau P;
    Gut; 2016 Jun; 65(6):954-62. PubMed ID: 26628508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hand-held fractional exhaled nitric oxide measurements as a non-invasive indicator of systemic inflammation in Crohn's disease.
    Quenon L; Hindryckx P; De Vos M; De Looze D; Joos G; Brusselle G; Peeters H
    J Crohns Colitis; 2013 Sep; 7(8):644-8. PubMed ID: 23083698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of disease location on fecal calprotectin levels in Crohn's disease.
    Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
    Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease.
    Sha S; Xu B; Wang X; Zhang Y; Wang H; Kong X; Zhu H; Wu K
    Diagn Microbiol Infect Dis; 2013 Mar; 75(3):245-51. PubMed ID: 23276768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.